UnitedHealth Group Incorporated cash flow to debt ratio of 25.13% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.

UnitedHealth Group Incorporated's free cash flow has decreased 22.36% from $20.70B last year to $16.07B, signaling decreasing performance

UnitedHealth Group Incorporated's debt to equity ratio is 0.70, which means that the company's assets are unhealthy financed, signaling financial risk.

UnitedHealth Group Incorporated's debt has decreased relative to shareholder equity from 0.83 last year to 0.70 today, signaling strengthened financials

UnitedHealth Group Incorporated has a net debt to EBITDA ratio of 2.18x, which is below the 3.00x threshold, indicating healthy leverage and financial stability

UnitedHealth Group Incorporated's interest coverage ratio of 5.57 indicates that earnings with good margin can cover interest payments on company debt

UnitedHealth Group Incorporated's profit margin has decreased (12.82%) in the last year from 3.60% to 3.14%, signaling decreasing performance

UnitedHealth Group Incorporated's short-term liabilities of $114.90B exceed its short-term assets of $90.58B, signaling financial risk

UnitedHealth Group Incorporated's return on assets of 4.56% is lower than the 5.00% threshold, indicating inefficient asset utilization

UnitedHealth Group Incorporated's return on equity of 14.40%, is lower than 15.00%, indicating bad performance

UnitedHealth Group Incorporated's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

UnitedHealth Group Incorporated had positive net income in 5 out of 5 years, indicating stable and consistent earnings

UnitedHealth Group Incorporated has positive free cash flow, indicating the company generates cash after capital expenditures

UnitedHealth Group Incorporated has a free cash flow yield of 4.33%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

UnitedHealth Group Incorporated's yearly earnings has decreased 16.31% since last year from $14.40B to $12.06B, signaling decreasing performance

UnitedHealth Group Incorporated's yearly revenue has increased 11.81% since last year from $400.28B to $447.57B, signaling increasing performance

ROIC 6.84% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

UnitedHealth Group Incorporated's 3-year revenue CAGR of 11.35% is positive, indicating growing revenue over the past 3 years

UnitedHealth Group Incorporated had revenue growth in 5 out of 5 years, indicating consistent revenue performance

UnitedHealth Group Incorporated had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

UnitedHealth Group Incorporated is overvalued relative to its fair value price of 111.78 based on Discounted Cash Flow model

UnitedHealth Group Incorporated has an earnings yield of 3.81%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings

UnitedHealth Group Incorporated is overvalued relative to its fair value price of 118.32 based on EBITDA multiple model

UnitedHealth Group Incorporated has an EV/EBITDA ratio of 18.28x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

UnitedHealth Group Incorporated is undervalued relative to its fair value price of 819.08 based on Earnings Fair Value model

UnitedHealth Group Incorporated's earnings growth over the measurement period is negative; the PEG ratio is not meaningful and the check fails.

UnitedHealth Group Incorporated has a price-to-book ratio of 3.50x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

UnitedHealth Group Incorporated has a price-to-sales ratio of 0.82x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue